Cart
sales@molnova.com
GSK-583
CAS No. 1346547-00-9
GSK-583( GSK583 | GSK 583 )
Catalog No. M11400 CAS No. 1346547-00-9
A potent, selective and orally bioavailable RIPK2 kinase inhibitor with IC50 of 5 nM and 2 nM for human and rat RIP2, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 59 | In Stock |
|
| 5MG | 106 | In Stock |
|
| 10MG | 181 | In Stock |
|
| 25MG | 302 | In Stock |
|
| 50MG | 441 | In Stock |
|
| 100MG | 654 | In Stock |
|
| 500MG | 1368 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGSK-583
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective and orally bioavailable RIPK2 kinase inhibitor with IC50 of 5 nM and 2 nM for human and rat RIP2, respectively.
-
DescriptionA potent, selective and orally bioavailable RIPK2 kinase inhibitor with IC50 of 5 nM and 2 nM for human and rat RIP2, respectively; displays robust selectivity against p38α and VEGFR2, and shows little or no inhibition of RIP3-dependent necroptotic cell death; potently and dose dependently inhibits MDP-stimulated TNFα production in human monocytes and human whole bolld with IC50 of 8 nM and 237 nM, respectively; inhibits MDP-induced inflammatory responses in vivo.
-
In Vitro——
-
In Vivo——
-
SynonymsGSK583 | GSK 583
-
PathwayApoptosis
-
TargetRIP kinase
-
RecptorRIP1|RIP3
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number1346547-00-9
-
Formula Weight398.4539
-
Molecular FormulaC20H19FN4O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 37 mg/mL
-
SMILESFC1=CC2=C(NN=C2NC3=CC=NC4=CC=C(S(=O)(C(C)(C)C)=O)C=C34)C=C1
-
Chemical Name4-Quinolinamine, 6-[(1,1-dimethylethyl)sulfonyl]-N-(5-fluoro-1H-indazol-3-yl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Haile PA, et al. J Med Chem. 2016 May 26;59(10):4867-80.
molnova catalog
related products
-
RIPGBM
RIPGBM is a cell type-selective, small molecule inducer of apoptosis in GBM cancer stem cells (CSCs) with EC50 of 220 nM (GBM 1 cells).
-
RIPK2-IN-5
RIPK2-IN-5 is a receptor-interacting protein kinase 2 (RIPK2) inhibitor with potential anti-inflammatory activity for the study of diseases caused by immune dysfunctions.
-
GSK872 HCl（1346546-6...
GSK872 HCl（1346546-69-7 free base） (GSK2399872A) is an effective and specific RIP3 kinase inhibitor. It binds RIP3 kinase domain with high affinity (IC50: 1.8 nM) and inhibits kinase activity (IC50: 1.3 nM).
